Cellular adhesion and the endothelium: E-selectin, L-selectin, and pan-selectin inhibitors

Hematol Oncol Clin North Am. 2014 Apr;28(2):341-54. doi: 10.1016/j.hoc.2013.11.010. Epub 2014 Jan 17.

Abstract

The pathophysiology of vasoocclusion is thought to involve a wide variety of adhesive interactions involving erythrocytes, leukocytes, and the endothelium. Selectins are expressed by leukocytes, platelets, and the endothelium, among other tissues. They contribute to a wide variety of physiologically important cell-cell interactions, including adhesion of all types of blood cells to the endothelium. In vitro, in vivo, and early-phase clinical studies suggest that E-selectin and pan-selectin inhibitors may be promising new therapeutic agents for the treatment of vasoocclusion in sickle cell disease.

Keywords: Adhesion; Endothelium; Integrins; Selectins; Sickle cell disease.

Publication types

  • Review

MeSH terms

  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / metabolism
  • Anemia, Sickle Cell / physiopathology
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / metabolism
  • Arterial Occlusive Diseases / physiopathology
  • Cell Adhesion / drug effects
  • Cell Communication / drug effects
  • E-Selectin / metabolism*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Glycolipids / pharmacology
  • Glycolipids / therapeutic use
  • Humans
  • L-Selectin / metabolism*

Substances

  • E-Selectin
  • Glycolipids
  • L-Selectin
  • rivipansel